Product Details
| Product Name: Tirzepatide | Min. Order: 1box |
| Purity: 99% | Supply Ability: 20tons |
| Release date: 2026/07/03 |
Tirzepatide Product Introduction
Overview Tirzepatide is a once?weekly, single?molecule dual agonist of the glucose?dependent insulinotropic polypeptide (GIP) and glucagon?like peptide?1 (GLP?1) receptors, developed by Eli Lilly. It is the first and only approved GIP/GLP?1 dual receptor agonist, with regulatory approvals in multiple markets for type 2 diabetes (T2DM) and, in some regions, for weight management and obstructive sleep apnea (OSA). In China, the brand name is Mounjaro
Company Profile Introduction
You may like
-
CAS:2023788-19-2
-
-
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $20.00 |
VIP1Y
|
Rongchuang International
|
2026-07-04 | |
| $1.00 |
VIP6Y
|
RongNa Biotechnology Co.,Ltd
|
2026-07-03 | |
| $10.00 |
VIP2Y
|
Shaanxi Cuikang Pharmaceutical Technology Co., Ltd.
|
2026-07-03 | |
| $15.00 |
VIP6Y
|
Shanghai UCHEM Inc.
|
2026-07-03 | |
| $80.00 |
VIP1Y
|
Guangzhou Pros Bio Technology Co., Ltd.
|
2026-07-03 | |
| $150.00 |
VIP1Y
|
Deepharma Inc
|
2026-07-03 | |
| $10.00 |
VIP1Y
|
Shanghai Zheng Peptide Plastic Co., Ltd.
|
2026-07-03 | |
| $1.00 |
VIP3Y
|
Jinan Million Pharmaceutical Co., Ltd
|
2026-07-03 | |
| $5.00 |
VIP2Y
|
Hebei Jiafan Trading Company Limited
|
2026-07-03 | |
| $20.00 |
VIP1Y
|
Ningbo Qingteng Plastic Cost.,Ltd.
|
2026-07-03 |
ChinaINQUIRY